Nanofilm Technologies (MZH) H1 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2023 earnings summary
21 Oct, 2026Executive summary
1H2023 revenue fell 34.4% YoY to S$73.2m amid seasonality and weak consumer electronics demand; PATMI was a S$7.6m loss.
Adjusted EBITDA of S$10.4m and operating cash flow of S$30.0m remained positive despite lower sales and costs tied to growth initiatives.
Financial highlights
Revenue S$73.2m, down 34.4% YoY from S$111.3m; gross profit S$23.4m, down 53.1% from S$50.0m.
Adjusted EBITDA S$10.4m, down 72.4% YoY from S$37.6m; PAT was a S$7.9m loss versus S$18.2m profit.
PATMI was a S$7.6m loss versus S$18.8m profit in 1H2022, primarily due to lower sales and spending on strategic initiatives.
Total cash and liquid assets stood at S$127.4m as of 30 June 2023.
Outlook and guidance
2H2023 revenue expected to exceed 1H2023, driven by seasonal peak production in Consumer; 2H2023 is not expected to be comparable with 2H2022.
Full-year profitability depends on end-consumer demand for upcoming 3C product launches and customers not tightening capex further.
Cost controls and pipeline contract execution will continue, balanced against peak-production needs and new business initiatives.
Strong operating leverage is anticipated when markets recover and production volumes return.
Latest events from Nanofilm Technologies
- Capacity investments and segment momentum underpin growth plans amid supply-chain disruption.MZH
Q4 2021 TU - Record FY2021 results and expanded capacity set the stage for FY2022 growth.MZH
H2 2021 - Revenue grew 24.2%, while startup and NPI costs pressured profit and margins.MZH
H1 2021 - 2H recovery lifted earnings and margins, underpinning conditional FY2024 growth expectations.MZH
H2 2023 - Headwinds cut FY2022 results, while expansion and the 2025 targets remained on track.MZH
H2 2022 - FY2025 revenue rose 20% and PAT 58%, led by AMBU growth and an IEBU recovery.MZH
H2 2025 - Revenue rose 29.6% as PATMI returned to profit and adjusted EBITDA grew 46.1%.MZH
H1 2025 - Revenue grew 13%, adjusted EBITDA rose 61.4%, and FY2024 growth is expected.MZH
H1 2024 - Revenue rose 15% and adjusted EBITDA 31%, supported by growth and global expansion.MZH
H2 2024